Beckman Coulter has launched two automated systems in the UK to ease rapidly increasing workloads in microbiology and virology departments.
The DxN Veris Molecular Diagnostics system, for sameday molecular viral load testing, and the Microscan Microbiology Systems for microorganism identification (ID) and antimicrobial susceptibility testing (AST), rapidly identify therapeutic pathways for patient management. This high-throughput testing streamlines laboratory workflows, and reduces time to patient therapy diagnoses. According to the Company this launch marks the advent of a significant investment in the UK microbiology market with further product introductions scheduled.